Related Experiment Video
Updated: May 25, 2026

10:37
Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Elevated interleukin-8 enhances prefrontal synaptic transmission in mice with persistent inflammatory pain
Guang-bin Cui1, Jia-ze An, Nan Zhang
1Department of Diagnostic Radiology, Tangdu Hospital, Xi’an 710032, China.
Molecular Pain
|February 14, 2012
Summary
Interleukin-8 (IL-8) up-regulation in the anterior cingulate cortex (ACC) enhances synaptic transmission, contributing to persistent inflammatory pain. Blocking IL-8 receptors reduces pain sensitivity.
Area of Science:
- Neuroscience
- Immunology
- Pain Research
Background:
- Interleukin-8 (IL-8) is implicated in inflammation and pain development.
- IL-8 expression elevates in the brain following peripheral inflammation.
- The anterior cingulate cortex (ACC) processes pain, but IL-8's role in its synaptic changes during chronic pain is unclear.
Purpose of the Study:
- To investigate IL-8 expression in the ACC and spinal cord after peripheral inflammation.
- To determine the effect of IL-8 on synaptic transmission in the ACC.
- To assess the therapeutic potential of blocking IL-8 receptors in inflammatory pain.
Main Methods:
- Hind-paw administration of complete Freund's adjuvant (CFA) in mice to induce peripheral inflammation.
- ELISA for quantifying IL-8 protein levels in the ACC, somatosensory cortex, and spinal cord.
- In vitro whole-cell patch-clamp recordings to analyze ACC synaptic transmission.
- Local infusion of repertaxin (IL-8 receptor blocker) and assessment of paw withdrawal latency.
Main Results:
- CFA induced chronic inflammation, leading to increased IL-8 expression in the ACC and spinal cord.
- IL-8 significantly enhanced ACC synaptic transmission by increasing neurotransmitter release probability.
- Repertaxin administration prolonged paw withdrawal latency, indicating reduced pain sensitivity.
Conclusions:
- IL-8 up-regulation in the ACC contributes to enhanced prefrontal synaptic transmission in persistent inflammatory pain.
- Targeting IL-8 signaling pathways may offer a novel therapeutic strategy for managing chronic pain.
